| Systemic inflammation markers and cancer incidence in the UK Biobank TH Nøst, K Alcala, I Urbarova, KS Byrne, F Guida, TM Sandanger, ... European journal of epidemiology 36 (8), 841-848, 2021 | 183 | 2021 |
| Redefining malignant pleural mesothelioma types as a continuum uncovers immune-vascular interactions N Alcala, L Mangiante, N Le-Stang, CE Gustafson, S Boyault, F Damiola, ... EBioMedicine 48, 191-202, 2019 | 58 | 2019 |
| Comparative performance of lung cancer risk models to define lung screening eligibility in the United Kingdom HA Robbins, K Alcala, AJ Swerdlow, MJ Schoemaker, N Wareham, ... British Journal of Cancer 124 (12), 2026-2034, 2021 | 38 | 2021 |
| Predictors of weight change in sedentary smokers receiving a standard smoking cessation intervention S Prod’hom, I Locatelli, K Giraudon, P Marques-Vidal, C Clair, R Bize, ... nicotine & tobacco research 15 (5), 910-916, 2013 | 32 | 2013 |
| Obesity and overweight associated with lower rates of colorectal cancer screening in Switzerland R Fischer, TH Collet, A Zeller, L Zimmerli, JM Gaspoz, K Giraudon, ... European journal of cancer prevention 22 (5), 425-430, 2013 | 25 | 2013 |
| Circulating markers of cellular immune activation in prediagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3) JY Huang, TL Larose, HN Luu, R Wang, A Fanidi, K Alcala, VL Stevens, ... International journal of cancer 146 (9), 2394-2405, 2020 | 24 | 2020 |
| The blood metabolome of incident kidney cancer: A case–control study nested within the MetKid consortium F Guida, VY Tan, LJ Corbin, K Smith-Byrne, K Alcala, C Langenberg, ... PLoS Medicine 18 (9), e1003786, 2021 | 19 | 2021 |
| Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program HA Robbins, K Alcala, EK Moez, F Guida, S Thomas, H Zahed, ... Annals of epidemiology 77, 1-12, 2023 | 15 | 2023 |
| The relationship between blood pressure and risk of renal cell carcinoma K Alcala, D Mariosa, K Smith-Byrne, D Nasrollahzadeh Nesheli, ... International journal of epidemiology 51 (4), 1317-1327, 2022 | 10 | 2022 |
| The blood proteome of imminent lung cancer diagnosis Nature communications 14 (1), 3042, 2023 | 9* | 2023 |
| Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools X Feng, WYY Wu, JU Onwuka, Z Haider, K Alcala, K Smith-Byrne, ... JNCI: Journal of the National Cancer Institute 115 (9), 1050-1059, 2023 | 2 | 2023 |
| Socioeconomic status and lung cancer incidence: An analysis of data from 15 countries in the Lung Cancer Cohort Consortium JU Onwuka, H Zahed, X Feng, K Alcala, M Johansson, HA Robbins, ... Cancer Research 83 (7_Supplement), 1950-1950, 2023 | 2 | 2023 |
| Kidney function and risk of Renal Cell Carcinoma K Alcala, H Zahed, R Cortez Cardoso Penha, N Alcala, HA Robbins, ... Cancer Epidemiology, Biomarkers & Prevention 32 (11), 1644-1650, 2023 | 1 | 2023 |
| Incident cancers attributable to using opium and smoking cigarettes in the Golestan cohort study K Alcala, H Poustchi, V Viallon, F Islami, A Pourshams, A Sadjadi, ... EClinicalMedicine 64, 2023 | 1 | 2023 |
| IL-18 and lower risk for lung cancer: Triangulated evidence from germline predictions, pre-diagnostic measurements, and tumor expression K Smith-Byrne, Y Chen, L Kachuri, PM Kapoor, F Guida, H Zahed, ... medRxiv, 2021.03. 26.21254400, 2021 | 1 | 2021 |
| Lung cancer risk assessment with the INTEGRAL protein panel: Preliminary results from development and validation in the Lung Cancer Cohort Consortium H Zahed, K Alcala, DC Muller, R Hung, M Johansson, HA Robbins, ... Cancer Research 84 (6_Supplement), 6095-6095, 2024 | | 2024 |
| statistical peer reviewers in 2023 J Aarestrup, E Abrams, M Absoud, L Abu-Raddad, A Agwu, C Agyemang, ... Health 37, 100858, 2024 | | 2024 |
| MA19. 05 Performance of Risk Prediction Models to Select Individuals for Lung Cancer Screening in the European Population X Feng, P Goodley, K Alcala, F Guida, M Johansson, HA Robbins, ... Journal of Thoracic Oncology 18 (11), S171, 2023 | | 2023 |
| OA07. 06 Development and Validation of a Protein-Based Lung Cancer Risk Prediction Model-Initial Results from the Lung Cancer Cohort Consortium (LC3) H Zahed, K Alcala, DC Muller, RJ Hung, HA Robbins, M Johansson Journal of Thoracic Oncology 18 (11), S60, 2023 | | 2023 |
| MA03. 08 Regular Use of Pharmaceutical Opioids and Subsequent Risk of Lung Cancer M Sheikh, K Alcala, D Mariosa, X Feng, P Sarich, M Weber, A Fournier, ... Journal of Thoracic Oncology 18 (11), S107-S108, 2023 | | 2023 |
Mattias JohanssonInternational Agency for Research on Cancer (IARC)Verified email at iarc.fr
